Steve Schonfeld’s Insys Therapeutics, Inc. INSY Stock Holding History

Steve Schonfeld’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-20,071	Closed	-$185K	–	807
2016 Q4	$185K	Buy	+20,071	New	+$227K	0.02%	511

Other funds holding INSY

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FHAM

Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCP

Fine Capital Partners New York $563M AUM 7.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Steve Schonfeld's INSY Position: Q1 2017 in Review

Steve Schonfeld sold out of Insys Therapeutics, Inc. (INSY) in Q1 2017, closing a stake of 20,071 shares — an estimated $185K sold.

Steve Schonfeld first reported a position in INSY in Q4 2016 and held it in 1 quarter. The position peaked at $185K in Q4 2016. 116 funds tracked by Wall St. Rank hold INSY as of Q1 2017.

Steve Schonfeld reported no remaining Insys Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
Steve Schonfeld sold 20,071 Insys Therapeutics, Inc. shares in Q1 2017, an estimated $185K.
Steve Schonfeld first reported a position in Insys Therapeutics, Inc. in Q4 2016 and held it in 1 quarter.
Steve Schonfeld's Insys Therapeutics, Inc. position peaked at $185K in Q4 2016.
116 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2017.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2017, filed 15 May 2017.